Skribble enters into partnership with Intrum
Zurich – Electronic signatures are in future set to be connected with a digital customer identity check. To this end, the signature specialists Skribble are entering into a partnership with the Swedish firm Intrum.
Travel startup gains notable investors
Zurich – The Trip Boutique uses artificial intelligence to offer personalized holidays. The startup has now impressed a number of investors, including Orascom founder Samih Sawiris and Elisabeth Stevens, former director at Booking.com.
Hemotune raises 5.1 million Swiss francs
Zurich – Hemotune has raised 5.1 million Swiss francs in a financing round. Investors included Occident, Zürcher Kantonalbank and a Korean medtech company. Hemotune has developed a medical device for blood purification.
HeiQ technology in coronavirus-proof yarn
London/Schlieren ZH – British company Coats is using textile technology from HeiQ, a startup from the Greater Zurich Area, to develop industrial yarns that protect against viruses. The textile technology is said to be among the first in the world that can effectively block COVID-19.
BOND Mobility acquires Roll2Go platform
Zurich/Uster – BOND Mobility, a Europe-wide shared mobility operator that provides e-bikes, has acquired the shared micromobility platform of Roll2Go, a spin-off from the Swiss Federal Institute of Technology (ETH) in Zurich. The platform offers mobility data analytics.
2D materials could facilitate smaller transistors
Zurich/Lausanne - ETH and EPFL researchers have identified 13 highly promising candidates from a total of 1,825 2D materials that could allow tiny, high-performance transistors to be built. This could provide fresh impetus to the miniaturization of electronic components.
Government reserves coronavirus drugs
Schlieren ZH – The Swiss government has signed a reservation contract for a Covid-19 drug developed by Molecular Partners. The University of Zurich spin-off intends to start clinical trials in the fall.
Universities of applied sciences helps start-ups
A strong ecosystem for start-ups has developed in the Greater Zurich Area. Universities of applied sciences, including the Zurich University of Applied Sciences (ZHAW) and Zurich University of the Arts (ZHdK), also represent key drivers behind the systematic promotion of start-ups in high-tech industries in particular.
Helsinn opens plant for cancer drugs
Lugano/Biasca TI - Helsinn Advanced Synthesis, the production-focused subsidiary of the pharmaceutical firm Helsinn, has put its largest cancer department to date into operation. This will be used for the development, analysis and manufacturing of clinical and commercial cancer drugs
Meet with an expansion expert
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line.